We are live on ! Find out more
JGGDR

JGP Global Gestao de Recursos Portfolio holdings

AUM $23.2M
1-Year Est. Return 88.58%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+88.58%
3 Year Est. Return
+303.94%
5 Year Est. Return
+476.72%
10 Year Est. Return
+633.34%
AUM
$120M
AUM Growth
-$74.5M
Cap. Flow
-$82.8M
Cap. Flow %
-68.79%
Top 10 Hldgs %
98.06%
Holding
42
New
1
Increased
5
Reduced
10
Closed
26

Top Sells

Rank Stock Value
1
BUD icon
AB InBev
BUD
+$18.3M
2
CRI icon
Carter's
CRI
+$12.3M
3
RIO icon
Rio Tinto
RIO
+$3.74M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.08M
5
CVS icon
CVS Health
CVS
+$1.91M

Sector Composition

Rank Sector Weight
1 Consumer Staples 48.24%
2 Healthcare 9.17%
3 Communication Services 0%
4 Materials 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$47.1M 39.16%
200,000
-300,000
-60% -$69.7M
KHC icon
2
Kraft Heinz
KHC
$30.7B
$46M 38.24%
506,888
+476,250
+1,554% +$42.9M
BUD icon
3
AB InBev
BUD
$156B
$12M 10%
109,700
-170,149
-61% -$18.3M
EWZ icon
4
CALL
iShares MSCI Brazil ETF
EWZ
$9.1B
$3.75M 3.11%
+100,000
New +$3.73M
INCY icon
5
Incyte
INCY
$23.4B
$2.03M 1.69%
15,188
+426
+3% +$54.2K
BMRN icon
6
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.9M 1.58%
21,624
+5,328
+33% +$474K
CELG
7
DELISTED
Celgene Corp
CELG
$1.76M 1.46%
14,131
-4,160
-23% -$498K
UNH icon
8
UnitedHealth
UNH
$387B
$1.6M 1.33%
9,772
-2,437
-20% -$399K
ALXN
9
DELISTED
Alexion Pharmaceuticals
ALXN
$1.12M 0.93%
9,245
-4,736
-34% -$611K
LLY icon
10
Eli Lilly
LLY
$1.05T
$670K 0.56%
7,969
-1,520
-16% -$122K
REGN icon
11
Regeneron Pharmaceuticals
REGN
$70.9B
$457K 0.38%
1,179
-1,943
-62% -$720K
TSRO
12
DELISTED
TESARO, Inc.
TSRO
$440K 0.37%
2,860
+1,133
+66% +$184K
SGEN
13
DELISTED
Seagen Inc. Common Stock
SGEN
$404K 0.34%
6,433
-15,612
-71% -$974K
EWZ icon
14
PUT
iShares MSCI Brazil ETF
EWZ
$9.1B
$375K 0.31%
10,000
-138,300
-93% -$5.17M
VRTX icon
15
Vertex Pharmaceuticals
VRTX
$123B
$365K 0.3%
3,339
-1,660
-33% -$146K
NBIX icon
16
Neurocrine Biosciences
NBIX
$17.2B
$299K 0.25%
6,903
+1,140
+20% +$48.8K
AAPL icon
17
Apple
AAPL
$4.9T
-18,276
Closed -$529K
ABBV icon
18
AbbVie
ABBV
$450B
-20,030
Closed -$1.25M
ACAD icon
19
Acadia Pharmaceuticals
ACAD
$4.38B
-28,913
Closed -$834K
AMGN icon
20
Amgen
AMGN
$198B
-6,833
Closed -$999K
BBWI icon
21
Bath & Body Works
BBWI
$4.21B
-4,723
Closed -$251K
BIIB icon
22
Biogen
BIIB
$30.4B
-3,312
Closed -$939K
BKNG icon
23
Booking.com
BKNG
$141B
-6,850
Closed -$402K
CRI icon
24
Carter's
CRI
$1.4B
-142,391
Closed -$12.3M
CVS icon
25
CVS Health
CVS
$137B
-24,162
Closed -$1.91M

Similar funds

JGP Global Gestao de Recursos's Q1 2017 Portfolio in Review

As of Q1 2017, JGP Global Gestao de Recursos held 42 positions worth $120M, down 38% from $195M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

JGP Global Gestao de Recursos withdrew a net $82.8M in Q1 2017, closing 26 positions and reducing 10 holdings. Its most notable exit was Carter's, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 48% of assets, up from 17% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, JGP Global Gestao de Recursos added an estimated $42.9M to Kraft Heinz.

  • JGP Global Gestao de Recursos added most to Kraft Heinz in Q1 2017, an estimated $42.9M increase.
  • JGP Global Gestao de Recursos's biggest Q1 2017 reduction was AB InBev, cutting an estimated $18.3M.
  • JGP Global Gestao de Recursos fully exited Carter's in Q1 2017, selling an estimated $12.3M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 98% of its $120M portfolio in Q1 2017.
  • JGP Global Gestao de Recursos opened 1 new position and closed 26 in Q1 2017.
  • JGP Global Gestao de Recursos's portfolio value fell 38% quarter-over-quarter to $120M.

Based on JGP Global Gestao de Recursos's 13F filing for Q1 2017, filed 9 May 2017.